Diffuse large B-cell lymphoma (DLBCL) is commonly classified by gene expression profiling according to its cell of origin (COO) into activated B-cell (ABC)-like and germinal center B-cell (GCB)-like subgroups. Here we report the application of label-free nano-liquid chromatography - Sequential Window Acquisition of all THeoretical fragment-ion spectra - mass spectrometry (nanoLC-SWATH-MS) to the COO classification of DLBCL in formalin-fixed paraffin-embedded (FFPE) tissue. To generate a protein signature capable of predicting Affymetrix-based GCB scores, the summed log(2)-transformed fragment ion intensities of 780 proteins quantified in a training set of 42 DLBCL cases were used as independent variables in a penalized zero-sum elastic net ...
The most frequent mature aggressive B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and B...
Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular ...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
Diffuse large B-cell lymphoma (DLBCL) is commonly classified by gene expression profiling according ...
Diffuse large B-cell lymphoma (DLBCL) is commonly classified by gene expression profiling according ...
Characterization of tumors at the molecular level has improved our knowledge of cancer causation and...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity with remarkably variable clinical ou...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity with remarkably variable clinical ou...
Correct classification of cancer patients into subtypes is a prerequisite for acute diagnosis and ef...
Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...
Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...
Cell‐of‐origin subclassification of diffuse large B cell lymphoma (DLBCL) into activated B cell‐like...
Multiple gene expression profiles have been identified in diffuse large B-cell lymphoma (DLBCL). Bes...
Diffuse large B-cell lymphoma (DLBCL) is the most common invasive type of non-Hodgkin lymphoma. Cell...
Precision medicine is modernizing strategies for clinical study design to help improve diagnoses gui...
The most frequent mature aggressive B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and B...
Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular ...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...
Diffuse large B-cell lymphoma (DLBCL) is commonly classified by gene expression profiling according ...
Diffuse large B-cell lymphoma (DLBCL) is commonly classified by gene expression profiling according ...
Characterization of tumors at the molecular level has improved our knowledge of cancer causation and...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity with remarkably variable clinical ou...
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous entity with remarkably variable clinical ou...
Correct classification of cancer patients into subtypes is a prerequisite for acute diagnosis and ef...
Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...
Diffuse large B-cell lymphoma-not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgr...
Cell‐of‐origin subclassification of diffuse large B cell lymphoma (DLBCL) into activated B cell‐like...
Multiple gene expression profiles have been identified in diffuse large B-cell lymphoma (DLBCL). Bes...
Diffuse large B-cell lymphoma (DLBCL) is the most common invasive type of non-Hodgkin lymphoma. Cell...
Precision medicine is modernizing strategies for clinical study design to help improve diagnoses gui...
The most frequent mature aggressive B-cell lymphomas are diffuse large B-cell lymphoma (DLBCL) and B...
Gene expression profiling (GEP) has stratified diffuse large B-cell lymphoma (DLBCL) into molecular ...
Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive lymphomas that can be c...